Product Information
FENTANYL 12 MCG/HR PATCH is a generic product labeled by Apotex Corp., priced at $9.8055 per EA under NDC 60505701002. Its NADAC has been published 477 times since Apr 6, 2016.
FDA first approved this application on Oct 20, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12 ug/h
Manufacturer
Apotex Corp.NDC
60505701002
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
5/21/2025
Active Ingredients
FENTANYLApproval Type
Generic (ANDA)
FDA Application
ANDA077449FDA Approved
10/20/2008
TE Code
AB
On Market Since
1/22/2016
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 12 MCG/HR PATCH has been published 477 times since Apr 6, 2016, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8055 per EA |
|---|---|
| All-time high | $14.5437 (Apr 13, 2016) |
| All-time low | $6.7833 (Nov 20, 2019) |
| Median price | $9.1637 |
| Average price | $9.3214 |
| Largest weekly change | +23.1% (Aug 18, 2021) |
| Weeks tracked | 477 |
| Tracking since | Apr 6, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+4.1%
5Y
+26.0%
All
-32.6%
Last surveyed May 21, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENTANYL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENTANYL 12 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 12 MCG/HR PATCH, manufactured by Apotex Corp., is $9.8055 per EA (NDC 60505701002), effective May 21, 2025.
How has the price of FENTANYL 12 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for FENTANYL 12 MCG/HR PATCH has declined 32.6%. It has been tracked across 477 weekly CMS publications since Apr 6, 2016.
What are the highest and lowest recorded NADAC prices for FENTANYL 12 MCG/HR PATCH?
Since Apr 6, 2016, the NADAC for FENTANYL 12 MCG/HR PATCH has ranged from a low of $6.7833 (Nov 20, 2019) to a high of $14.5437 (Apr 13, 2016), with a median of $9.1637 per EA.
Are there cheaper alternatives to FENTANYL 12 MCG/HR PATCH?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENTANYL 12 MCG/HR PATCH, is $8.9890 per EA — about 8% below FENTANYL 12 MCG/HR PATCH.
Who manufactures FENTANYL 12 MCG/HR PATCH?
FENTANYL 12 MCG/HR PATCH (NDC 60505701002) is labeled by Apotex Corp., and CMS classifies it as a generic product.